Elysium gets ChromaDex, Dartmouth vitamin patents invalidated
23-09-2021
Ukrainians plead guilty to trafficking counterfeit drugs into the US
20-07-2020
stock_colors / iStockphoto.com
The US Department of Justice (DoJ) has asked for an injunction to stop a Louisiana-based drug and dietary supplement manufacturer from distributing misbranded and unapproved new drugs and dietary supplements.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Department of Justice, FDA, US District Court for the Western District of Louisiana, Pick and Pay, Cili Minerals, FDCA, drugs, supplements, misbranding,
